Sebastian Wanless
Corporate Officer/Principal bij TCB Newco Ltd.
Profiel
Sebastian Wanless is currently working as a Senior Clinical Director at TCB Newco Ltd.
He previously worked as a Senior Medical Director at Bristol-Myers Squibb Foundation from 2003 to 2007.
Additionally, he worked as a Director-Clinical Operations at TC Biopharm (Holdings) Plc from 2020 to 2022.
Actieve functies van Sebastian Wanless
| Bedrijven | Functie | Begin |
|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
Eerdere bekende functies van Sebastian Wanless
| Bedrijven | Functie | Einde |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 01-09-2022 |
| Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 01-01-2007 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
| Bristol-Myers Squibb Foundation |
